# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-22-028070
Filing Date
2022-02-28
Accepted
2022-02-28 16:06:15
Documents
89
Period of Report
2021-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10K | cldx-20211231x10k.htm iXBRL | 10-K | 2247407
2 | EX-21.1 | cldx-20211231xex21d1.htm | EX-21.1 | 7153
3 | EX-23.1 | cldx-20211231xex23d1.htm | EX-23.1 | 2324
4 | EX-31.1 | cldx-20211231xex31d1.htm | EX-31.1 | 10129
5 | EX-31.1 | cldx-20211231xex31d2.htm | EX-31.1 | 10510
6 | EX-32 | cldx-20211231xex32.htm | EX-32 | 10760
12 | GRAPHIC | cldx-20211231x10k002.jpg | GRAPHIC | 38234
| Complete submission text file | 0001104659-22-028070.txt |  | 8423851

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | cldx-20211231.xsd | EX-101.SCH | 47011
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | cldx-20211231_cal.xml | EX-101.CAL | 66336
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cldx-20211231_def.xml | EX-101.DEF | 232755
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cldx-20211231_lab.xml | EX-101.LAB | 510814
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cldx-20211231_pre.xml | EX-101.PRE | 405382
83 | EXTRACTED XBRL INSTANCE DOCUMENT | cldx-20211231x10k_htm.xml | XML | 1334735

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 22689341
SIC: 2835 In Vitro & In Vivo Diagnostic Substances